• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[霍奇金淋巴瘤放化疗联合治疗期间的即时血液学毒性]

[Immediate hematological toxicity during combination chemotherapy-radiotherapy of Hodgkin's disease].

作者信息

Peiffert D, Bey P, Lederlin P, Conroy T, Witz F

机构信息

Service de Radiothérapie, Centre A.-Vautrin, Vandoeuvre-lès-Nancy, France.

出版信息

Bull Cancer. 1989;76(4):373-82.

PMID:2473814
Abstract

The hematologic immediate toxicity during radiotherapy for Hodgkin's disease was studied from a series of 72 patients with stage IIB or III who received 3 courses or more of chemotherapy before radiotherapy. The toxicity in the group of 36 of them who received total nodal irradiation (TNI) was the most important. Sixteen of the 28 TNI had irradiation interrupted, 12 of them began with inverted Y type. The blood cells count at the beginning of the treatment was crucial; only 16% of the patients had interruption of irradiation when the blood cells count was normal; on the other side, 63% had interruption when the blood cells count was abnormal (P less than 0.05). Toxicity was due to the daily destruction of the dividing bone marrow stem cells located in the irradiated area, from the first day of treatment; there was a progressive decrease in the pool of these stem cells within a late resaturation. The absence of resaturation of this pool after initial chemotherapy and after the first part of irradiation explained the immediate and durable toxicity; in the same way, inverted Y irradiation destroyed a great part of active bone marrow (40%) and the pool of remaining stem cells with high mitotic index would be located in areas irradiated subsequently. So, waiting for the absolute normalisation of blood cells count before beginning irradiation and start irradiation by mantle field (rather than inverted Y) seem to be the 2 measures able to reduce the number of interruptions of irradiation due to hematotoxicity.

摘要

对72例IIB期或III期霍奇金病患者进行了研究,这些患者在放疗前接受了3个疗程或更多疗程的化疗,以探讨放疗期间的血液学即时毒性。其中36例接受全淋巴结照射(TNI)的患者的毒性最为显著。28例接受TNI的患者中有16例放疗中断,其中12例从倒Y型开始。治疗开始时的血细胞计数至关重要;血细胞计数正常时,只有16%的患者放疗中断;另一方面,血细胞计数异常时,63%的患者放疗中断(P<0.05)。毒性是由于从治疗第一天起,位于照射区域的正在分裂的骨髓干细胞每日遭到破坏;这些干细胞池在后期再饱和过程中逐渐减少。初始化疗后和第一部分放疗后该干细胞池未再饱和,这解释了即时和持久的毒性;同样,倒Y型照射破坏了大部分活跃骨髓(40%),剩余有高有丝分裂指数的干细胞池将位于随后照射的区域。因此,在开始放疗前等待血细胞计数绝对正常,并采用斗篷野(而非倒Y型)开始放疗,似乎是能够减少因血液毒性导致放疗中断次数的两项措施。

相似文献

1
[Immediate hematological toxicity during combination chemotherapy-radiotherapy of Hodgkin's disease].[霍奇金淋巴瘤放化疗联合治疗期间的即时血液学毒性]
Bull Cancer. 1989;76(4):373-82.
2
Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease.化疗期间低急性血液学毒性预示晚期霍奇金淋巴瘤疾病控制效果降低。
Ann Hematol. 2004 Mar;83(3):176-82. doi: 10.1007/s00277-003-0727-9. Epub 2003 Dec 12.
3
Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.霍奇金病放化疗后不同程度肺毒性患者运动时的心肺反应
Anticancer Res. 2009 Feb;29(2):777-83.
4
Toxicity of a combination of ABVD chemotherapy and mediastinal irradiation for Hodgkin's disease patients with massive initial mediastinal involvement.ABVD化疗与纵隔放疗联合应用于初治纵隔广泛受累的霍奇金病患者的毒性反应
Bull Cancer. 1988;75(8):801-6.
5
[Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].70例霍奇金淋巴瘤患者一线及挽救治疗后的结局:单中心经验
Sangre (Barc). 1998 Jun;43(3):179-84.
6
Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Treatment of Cancer.
NCI Monogr. 1988(6):303-10.
7
Male infertility caused by the chemotherapy of Hodgkin's disease: MOPP versus ABVD.霍奇金淋巴瘤化疗导致的男性不育:MOPP方案与ABVD方案的比较
Acta Eur Fertil. 1983 May-Jun;14(3):221-2.
8
Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.以环磷酰胺、长春新碱、丙卡巴肼、泼尼松、阿霉素、博来霉素和长春花碱组成的联合化疗方案(C-MOPP/ABV)作为晚期霍奇金病患者的一线治疗方案。
Cancer. 2000 May 1;88(9):2142-8.
9
Analysis of the risk of solid tumor following Hodgkin's disease.霍奇金淋巴瘤后实体瘤风险分析。
Haematologica. 1997 Jan-Feb;82(1):57-63.
10
Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group.复发难治性霍奇金淋巴瘤患者的挽救性放疗:来自德国霍奇金淋巴瘤研究组的回顾性分析
J Clin Oncol. 2005 Mar 1;23(7):1522-9. doi: 10.1200/JCO.2005.05.022. Epub 2005 Jan 4.